Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
Titel:
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
Auteur:
Smolen, Josef S Kay, Jonathan Doyle, Mittie K Landewé, Robert Matteson, Eric L Wollenhaupt, Jürgen Gaylis, Norman Murphy, Frederick T Neal, Jeffrey S Zhou, Yiying Visvanathan, Sudha Hsia, Elizabeth C Rahman, Mahboob U